8th ISABS Conference


Eighth ISABS Conference on Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine, Split, Croatia, June 24-28, 2013!


Invited speakers (confirmed):

Inaugural Plenary Session: Science and Public Security
Zvia Agur (Institute for Medical BioMathematics, Tel Aviv, Israel): Can one theory guide both personalized medicine and national security policies?
Christopher Asplen (Global Alliance for Rapid DNA Testing, Chalfont, Pennsylvania, USA): Future impact of rapid DNA technology on law enforcement
Isaac Ben-Israel (Tel Aviv University, Tel Aviv, Israel): Forensics of cyber crime: The problem of attribution
Henry Lee (University of New Haven, West Haven, Connecticut, USA): Application of DNA evidence in public safety
Andre Terzic(Mayo Clinic, Rochester, Minnesota, USA): Regenerative medicine: a new paradigm

Nobel Lectures
Aaron Ciechanover (Nobel Prize in Chemistry 2004; Technion, Haifa, Israel): Revolution of personalized medicine: Will we cure all diseases and at what cost?
Robert Huber (Nobel Prize in Chemistry 1988; Max-Planck-Institute, Martinsried, Germany): Protein structures at the interface of physics, chemistry and biology
Ada Yonath(Nobel Prize in Chemistry 2009; Weizmann Institute of Science, Rehovot, Israel): From basic science to better antibiotics

Forensic Program
Šimun Anđelinović (University of Split, Split, Croatia): Virtual authopsy and forensic anthropology of mummified saint bodies
Kenneth Aschheim (New York University, New York, New York, USA): Forensic odontology in disaster victim identification: new technologies
Kaye Ballantyne (Victoria Police Forensic Services Department, Macleod, Victoria, Australia): Improved forensic Y-chromosome analysis
Corina Benschop (Netherlands Forensic Institute,Hague, The Netherlands): Low template DNA analysis and interpretation
Frederick Bieber (Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA): Role of statistical genetics in mass disaster management
Veronique Bourdon (Azur Genetique, Nice, France): Optimization of human mtDNA control region sequencing for forensic applications.
Zoran Budimlija (Office of Chief Medical Examiner, New York City, New York, USA): Twelve years of World Trade Center Human Identification Project
Barbara Butcher (Office of Chief Medical Examiner, New York City, New York, USA): Science of mass fatality management
Cassandra Calloway (Children's Hospital & Research Center Oakland, Oakland, California, USA): Analysis of DNA mixtures and degraded DNA by clonal sequencing
Theresa Caragine
(Office of Chief Medical Examiner, New York City, New York, USA): Forensic casework after 9/11: Implementing new technologies
Angel Carracedo (University of Santiago de Compostela, Santiago de Compostela, Spain): New genomic technologies in forensic science
Katja Drobnič (National Forensic Laboratory, Ljubljana, Slovenia): Advanced methods in forensic practice
Santo Davide Ferrara (University of Padua, Padua, Italy): Perspectives of biomedicolegal sciences
Benjamin Figura (Office of Chief Medical Examiner, New York, New York, USA): Anthropology and fingerprinting: New techniques for identification
Dan Frumkin (Nucleix, Tel Aviv, Israel): Forensic epigenetics
Cordula Haas (Institute of Legal Medicine, University of Zürich, Zürich, Switzerland): Gene expression in forensic sciences
Mitchell Holland (Penn State University, University, Pennsylvania, USA): Forensic applications of NextGen Sequencing on 454 LifeSciences GS Junior and Illumina MiSeq instruments
Ed Huffine (Bode Technology, Lorton, Virginia, USA): From Forensic Investigations to Medical Applications, the Increasing Impact of DNA Testing
Manfred Kayser (University of Rotterdam, Rotterdam, The Netherlands): Forensic DNA phenotyping
Peter de Knijff (University of Leiden, Leiden, The Netherlands): Deep sequencing of 750 complete Dutch mtDNA genomes using NextGen Sequencing
Timothy Palmbach (University of New Haven, Connecticut, USA): Leveraging the power of DNA analysis in the war on human trafficking
Walther Parson (Institute of Legal Medicine, Innsbruck Medical University, Insbruck, Austria): Forensic applications of NextGen Sequencing on LifeTechnologies Ion PGM instrument
Dragan Primorac (University of Split and University of Osijek, Croatia; Penn State University and University of New Haven, USA): Epigenetic predictors of age
Antti Sajantila (University of Helsinki, Helsinki, Finland): Progress in forensic pharmacogenomics
Moses Schanfield (George Washington University, Washington, District of Columbia, USA): Population variation in X chromosome STR markers: Forensic and anthropologic considerations
Peter Vallone (National Institute of Standards and Technology, Gaithersburg, Maryland, USA): Characterization of reference standards with NextGen Sequencing platforms
Elisa Wurmbach (Office of Chief Medical Examiner, New York City, New York, USA): Improved eye and skin color prediction based on 8 SNPs

Translational Medicine Program
Chiara Bonini (San Raffaele Scientific Institute, Milan, Italy): TCR gene editing for treatment of hematological malignancies
Malcolm Brenner (Baylor College of Medicine, Houston, Texas, USA): How to make T cells a standard of care for cancer?
Renier Brentjens (Memorial Sloan-Kettering Cancer Center, New York, New York, USA): Moving CAR modified T cell therapy of cancer forward in the clinic
Robert Deans (Athersys Inc, Cleveland, Ohio, USA): Adherent stem cells for CNS injury
Henry Erlich (Roche Molecular Systems, Pleasanton, California, USA): Next Generation Sequencing in analysis of HLA polymorphism: clinical and research applications
Arezou Ghazani (Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, USA): Advances in nanotechnology and diagnostics
David Goldstein (Duke University, Durham, North Carolina, USA): Exome sequencing of rare monogenic diseases
Michael Jensen (Seattle Children's Hospital, Seattle, Washington, USA): Enhancing IQ of chimeric antigen receptor-redirected T cells
Doron Lancet (Weizmann Institute of Science, Rehovot, Israel): Biological tales of human disease mutations
Steven Moran (Mayo Clinic, Rochester, Minnesota, USA): Hand and face transplantation at Mayo Clinic
Moien Kanaan (Bethlehem University, Bethlehem, Palestine): Towards the application of exome sequencing in the clinic
Franklyn Prendergast (Mayo Clinic, Rochester, Minnesota, USA): Heterogeneity and accuracy of diagnostics for personalized medicine
Yoel Rak (Tel-Aviv University, Tel Aviv, Israel): Neanderthal man's place in nature
Dražen Raucher (University of Mississippi, Jackson, Mississippi, USA): Thermoresponsive biopolymers for tumor-specific drug delivery
Isobel Scarisbrick (Mayo Clinic, Rochester, Minnesota, USA): Pharmacological approach to spine cord injury regeneration
John Sinden (ReNeuron, Guildford, Surrey, United Kingdom): Neuronal cell therapy for stroke
Rafael Sierra (Mayo Clinic, Rochester, Minnesota, USA): Hip decompression by bone marrow concentrate in early osteonecrosis of femoral head
David I. Smith (Mayo Clinic, Rochester, Minnesota, USA): Next generation transcriptome analysis of human cancer
Carmen Terzic (Mayo Clinic, Rochester, Minnesota, USA): Cardiac circulating progenitor cells and cardiac regeneration
Peter Underhill (Stanford University, Stanford, California, USA): Patterns of Y-chromosome diversification
Richard Villems (University of Tartu and Estonian Biocentre, Tartu, Estonia): Genetics of Slavic-speaking peoples: Patrilineal, matrilineal and autosomal portraits
Stanimir Vuk-Pavlović (Mayo Clinic, Rochester, Minnesota, USA): Stemness arisen
Peter de Waele (Cardio3 Biosciences, Mont-Saint-Guibert, Belgium): Treating congestive heart failure by autologous adherent progenitors
Scott Waldman (Thomas Jefferson University, Philadelphia, Pennsylvania, USA): A common molecular mechanism at the intersection of obesity and colorectal cancer
Raphael Zidovetzki(University of California Riverside, Riverside, California, USA): Genetic scrutiny of systemic lupus erythematosus, a prototypic autoimmune disease

Workshop "Adapting Clinical Trials to Modern Cancer Therapy"
Zwi Berneman (University of Antwerp, Antwerp, Belgium): Clinical perspectives of immunotherapy of hematopoietic malignancies
Moran Elishmereni (Institute for Medical BioMathematics, Tel Aviv, Israel): Dynamic personalization of clinical trials 1
Mauro Gasparini (Politecnico di Torino, Torino, Italy): New statistical tools fornovel approaches to clinical trials in personalized medicine
Yuri Kogan (Institute for Medical BioMathematics, Tel Aviv, Israel): Dynamic personalization of clinical trials 2
Manish Kohli (Mayo Clinic, Rochester, Minnesota, USA): Use of biomarkers in personalized therapy of prostate cancer

Workshop "Glycoscience in Personalized Medicine"
Harry Campbell (University of Edinburgh, Edinburgh, Scotland, United Kingdom): IgG and plasma glycome in colorectal cancer
John Hannover (National Institutes of Health, Behesda, Maryland, USA): Hexosamine signalling pathway
Gordan Lauc (University of Zagreb, Zagreb, Croatia): Common polymorphisms in glycosylation and human diseases
Dirk Lefeber (Radboud University, Nijmegen, The Netherlands): Congential disorders of glycosylation
Falk Nimmerjahn (Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany):Role of Fc glycosylation in IgG function
Igor Rudan (University of Edinburgh, Edinburgh, Scotland, United Kingdom): GWAS analysis of the human plasma glycome
Tim Spector (Kings College London, London, England, United Kingdom): Genetics and epigenetics of IgG glycosylation in twins
Vlatka Zoldoš (University of Zagreb, Zagreb, Croatia): Epigenetic regulation of protein glycosylation